Anti-ASAH1 antibody [EPR24476-30]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal ASAH1 antibody. Suitable for WB, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 3 publications.
View Alternative Names
ASAH, HSD-33, HSD33, ASAH1, Acid ceramidase, AC, ACDase, Acid CDase, Acylsphingosine deacylase, Glycosylceramide deacylase, N-acylethanolamine hydrolase ASAH1, N-acylsphingosine amidohydrolase, Putative 32 kDa heart protein, PHP32
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
Immunohistochemical analysis of paraffin-embedded human bladder cancer tissue labelling ASAH1 with ab282276 at 1/5000 dilution (0.118 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on bladder cancer. The section was incubated with ab282276 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
Immunohistochemical analysis of paraffin-embedded human colon tissue labelling ASAH1 with ab282276 at 1/5000 dilution (0.118 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human colon (PMID : 29920241). The section was incubated with ab282276 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
Immunohistochemical analysis of paraffin-embedded human breast cancer tissue labelling ASAH1 with ab282276 at 1/5000 dilution (0.118 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human breast cancer. The section was incubated with ab282276 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
Immunohistochemical analysis of paraffin-embedded human colon cancer tissue labelling ASAH1 with ab282276 at 1/5000 dilution (0.118 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human colon cancer. The section was incubated with ab282276 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
Immunohistochemical analysis of paraffin-embedded human kidney tissue labelling ASAH1 with ab282276 at 1/5000 dilution (0.118 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human kidney. The section was incubated with ab282276 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
Immunohistochemical analysis of paraffin-embedded human cerebrum tissue labelling ASAH1 with ab282276 at 1/5000 dilution (0.118 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human cerebrum. The section was incubated with ab282276 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IP
Supplier Data
Immunoprecipitation - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
ASAH1 was immunoprecipitated from 0.35 mg SK-MEL-28 (human malignant melanoma cell ) whole cell lysate with ab322109 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab322109 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : SK-MEL-28 (human malignant melanoma cell ) whole cell lysate
Lane 2 : ab322109 IP in SK-MEL-28 (human malignant melanoma cell ) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab322109 in SK-MEL-28 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST
The IP experiment was performed by ab322109 using SK-MEL-28 lysate. The blot was probed by another anti-ASAH1 antibody (ab282276)(1 : 1000 dilution).
All lanes:
Immunoprecipitation - Anti-ASAH1 antibody [MJF-D29767-517] (<a href='/en-us/products/primary-antibodies/asah1-antibody-mjf-d29767-517-ab322109'>ab322109</a>) at 1/30 dilution
All lanes:
SK-MEL-28 (human malignant melanoma cell ) whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profile/molecular weight observed is consistent with what has been described in the literature (PMID : 7744740, 26553872, 30254208).
Exposure time : 70 seconds
All lanes:
Western blot - Anti-ASAH1 antibody [EPR24476-30] (ab282276) at 1/1000 dilution
Lane 1:
Human colon tissue lysate at 40 µg
Lane 2:
Human spleen tissue lysate at 40 µg
Lane 3:
Human heart tissue lysate at 40 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/2000 dilution
Predicted band size: 45 kDa
Observed band size: 36 kDa,37 kDa
false
- WB
Lab
Western blot - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profile/molecular weight observed is consistent with what has been described in the literature (PMID : 7744740, 26553872, 30254208).
Negative control : A375 (PMID : 26553872, 30254208); MDA-MB-231 (PMID : 26553872).
Exposure time : 37 seconds
All lanes:
Western blot - Anti-ASAH1 antibody [EPR24476-30] (ab282276) at 1/1000 dilution
Lane 1:
SK-MEL-28 (human malignant melanoma) whole cell lysate at 20 µg
Lane 2:
MeWo (human malignant melanoma fibroblast) whole cell lysate at 20 µg
Lane 3:
A375 (human malignant melanoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
MDA-MB-231 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 45 kDa
Observed band size: 37 kDa
false
- WB
Lab
Western blot - Anti-ASAH1 antibody [EPR24476-30] (AB282276)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profile/molecular weight observed is consistent with what has been described in the literature (PMID : 7744740, 26553872, 30254208).
Exposure time : 147 seconds
All lanes:
Western blot - Anti-ASAH1 antibody [EPR24476-30] (ab282276) at 1/1000 dilution
Lane 1:
Mouse spleen tissue lysate at 40 µg
Lane 2:
Mouse colon tissue lysate at 40 µg
Lane 3:
Rat spleen tissue lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 45 kDa
Observed band size: 36 kDa
false
Related conjugates and formulations (1)
-
Anti-ASAH1 antibody [EPR24476-30] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ASAH1 influences several important cellular processes by controlling the levels of ceramide and sphingosine. These lipids are not just structural components of membranes; they participate actively in cell signaling. ASAH1 exists as part of a larger complex that includes other enzymes involved in sphingolipid metabolism. Changes in ceramide levels influence apoptosis and cell proliferation indicating ASAH1's role as a regulator in these processes.
Pathways
ASAH1 is central to the sphingolipid metabolism pathway. This pathway is interconnected with the apoptosis signaling pathway. By converting ceramide to sphingosine ASAH1 links the complex ceramide/sphingosine balance affecting cell survival and death decisions. It interacts with other enzymes such as sphingosine kinase 1 and ceramide synthases which further maintain the dynamic regulation between sphingosine and ceramide levels.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Translational cancer research 13:1954-1968 PubMed38737677
2024
Applications
Unspecified application
Species
Unspecified reactive species
Infection and drug resistance 16:2573-2588 PubMed37144155
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34769061
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com